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A. Suppl Figure. 9 Determining metastatic competence of commonly used prostate cancer cell lines based on concordance with the E6.5 gene expression signature.
D e lta 9 0 % D is ta n t M e ta s ta s is -F re e S u rv iv

FIGURES Suppl Figure 1: Kaplan-Meier curves of distant metastasis-free survival (DMFS) in
breast cancer patients stratified by expression of the E6.5-, the adult-, or the EMT gene expression signature, were plotted using patient data from four independent studies 1, 2, 3, 4 [Data from one of the cohorts is presented in Fig. 5 , the remaining are presented here]. Log-rank tests were used to assess statistical significance of differences in DMFS based on concordance with each signature. p<0.05 was considered as the necessary cutoff for statistical significance.
Suppl Figure 2: Kaplan-Meier curves of recurrence-free survival (RFS) in breast
cancer patients stratified by expression of the E6.5-, the adult-, or the EMT gene expression signature, were plotted using patient data from four independent studies 5, 6, 7, 8 [Data from one of the cohorts is presented in Fig. 5 , the remaining are presented here]. Log-rank tests were used to assess statistical significance of differences in RFS based on concordance with each signature. p<0.05 was considered as the necessary cutoff for statistical significance.
Suppl Figure 3:
A quantitative representation of the predicted relative metastatic abilities of various human breast cancer cell lines based on their E6.5-(A) or Adult-(B) scores.
Suppl Figures 4, 5:
Kaplan-Meier curves of distant metastasis-free survival (DMFS) in breast cancer patients stratified by expression of CDH1, PRRX1, TCF-8, SNAI2, VIM and TWIST1, were plotted using patient data from three independent studies [GSE7390 statistical significance of differences in DMFS based on concordance with expression of each gene. p<0.05 was considered as the necessary cutoff for statistical significance.
Suppl Figures 6, 7:
Kaplan-Meier curves of recurrence-free survival (RFS) in breast cancer patients stratified by expression of CDH1, PRRX1, TCF-8, SNAI2, VIM and TWIST1, were plotted using patient data from three independent studies [GSE12276 6 , GSE4922_UPPSALA 7 , and GSE1653 8 ]. Log-rank tests were used to assess statistical significance of differences in RFS based on concordance with each signature. p<0.05 was considered as the necessary cutoff for statistical significance.
Suppl Figure 8:
Well-characterized EMT-and stem cell-markers used for comparative analyses with the newly identified E6.5 gene expression signature. 39 genes were selected on the basis of their established EMT/stem cell-related functions. Panel A shows the full list of compared genes. The scatter plot in panel B shows compiled Kaplan-Meier curves of distant metastasis-free survival (DMFS) in breast cancer patients stratified by expression of EMT-and stem cell-markers listed in A, plotted using patient data from four independent studies 1, 2, 3, 4 . The scatter plot in panel C shows compiled Kaplan-Meier curves of recurrence-free survival (RFS) in breast cancer patients stratified by expression of EMT-and stem cell-markers listed in A, plotted using patient data from four independent studies 5, 6, 7, 8 .
Suppl Figure 9:
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